This page shows the latest companion diagnostics news and features for those working in and with pharma, biotech and healthcare.
There were people who developed drug-delivery systems. There were others who sold companion diagnostics. ... And, if not genotype-specific, many treatments are guided by companion diagnostics looking for biomarkers.
Value created beyond the pill, such as companion diagnostics and devices, are good examples of environmental selection, while me-too products that are not granted market access illustrate the market disfavouring
As with other ‘personalised medicine’ drugs, the company’s commercial division is aiming to maximise uptake by broadening access to companion diagnostics which can identify BRCA mutations in patients across these
The second kept on looking for whole-disease area blockbusters long after companion diagnostics had fractured its market.
Prior to the approval of F1CDx, most companion diagnostics for cancer matched one test to one drug, but the FDA said that using Foundation’s test could identify which patients with ... There has also been movement at the federal level in the US, with
Foundation Medicine is a major player in the emerging field of next generation cancer diagnostics and genomic profiling, and two developments yesterday confirmed it as a leader in what will undoubtedly ... If approved, this test could be the
More from news
Approximately 3 fully matching, plus 31 partially matching documents found.
companion diagnostics.
Diagnostics and cracking the market access code. For many of the company’s new generation of treatments, the uptake of companion diagnostics into routine clinical practice is another part of the ... Reic said the adoption of diagnostics into standard
The response has been a surge of interest in developing novel companion biomarkers, and biomarkers that allow personalisation of therapy. ... FDA is stimulating this approach and one can see the development of, for instance, TMB assays, targeted gene
9. RUTH MARCH. Precision medicine leader. Precision medicine and the use of companion diagnostics now plays a fully integrated role in many successful new cancer therapies. ... But how do you deliver these companion diagnostics to healthcare systems and
This encompasses approaches to detecting cancers earlier, including novel techniques such as liquid biopsies (aka circulating tumour DNA tests) and new companion diagnostics.
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.
FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president. ... It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised
Commenting on Pao's appointment, Reed said: "William is recognised as one of the world's leading molecular oncologists, with world class expertise in targeted cancer therapeutics, translational medicine, molecular diagnostics, ... diagnostics company,
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new FoundationOne CDx, the first and
Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.
Medical devices and diagnostics. Our experience covers everything from insulin pens to large-scale surgical systems. ... Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....